šŸ“¢ Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia

Oct 22, 2024 | News

Moleac is excited to announce a significant milestone in the journey of NeuroAiD II MLC901 asĀ š—£š—§ š—™š—²š—暝—暝—¼š—» š—£š—®š—æ š—£š—µš—®š—暝—ŗš—®š—°š—²š˜‚š˜š—¶š—°š—®š—¹š˜€Ā will become our exclusive partner inĀ IndonesiaĀ effectiveĀ Jan 1Ė¢įµ—Ā 2025.

We are immensely grateful for the fruitful 12-year partnership withĀ PT Mersifarma Tirmaku Mercusana,Ā and we sincerely thank them for their invaluable contributions to our success inĀ Indonesia. As we embark on a new chapter, we are thrilled to welcomeĀ PT Ferron Par PharmaceuticalsĀ ā€” a member ofĀ Dexa GroupĀ ā€” as our new exclusive commercial partner.
This partnership marks a crucial milestone in our mission to widen access to our groundbreaking products, supporting healthcare professionals in enhancing outcomes for patients recovering from stroke, traumatic brain injuries, and neurodegenerative diseases.

With PT Ferron Par Pharmaceuticals, a leader renowned for its market expertise and operational excellence, we are confident in our accelerated growth and the expanded availability of NeuroAiD II MLC901 to those in need.

We look forward to a future of growth and continued innovation as we extend the reach of NeuroAiD II MLC901 inĀ IndonesiaĀ to benefit more patients.

Access to the full press release here: https://www.prnewswire.com/news-releases/moleac-announces-pt-ferron-par-pharmaceuticals-as-new-exclusive-partner-in-indonesia-302281877.html